185 related articles for article (PubMed ID: 27909050)
21. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.
Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
[TBL] [Abstract][Full Text] [Related]
23. NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway.
He W; Cheng F; Zheng B; Wang J; Zhao G; Yao Z; Zhang T
Aging (Albany NY); 2021 May; 13(10):14015-14038. PubMed ID: 34030133
[TBL] [Abstract][Full Text] [Related]
24. A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data.
Zhao H; Leppert JT; Peehl DM
PLoS One; 2016; 11(1):e0146505. PubMed ID: 26814892
[TBL] [Abstract][Full Text] [Related]
25. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans.
Bielesz B; Sirin Y; Si H; Niranjan T; Gruenwald A; Ahn S; Kato H; Pullman J; Gessler M; Haase VH; Susztak K
J Clin Invest; 2010 Nov; 120(11):4040-54. PubMed ID: 20978353
[TBL] [Abstract][Full Text] [Related]
26. Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
Fabrizio FP; Costantini M; Copetti M; la Torre A; Sparaneo A; Fontana A; Poeta L; Gallucci M; Sentinelli S; Graziano P; Parente P; Pompeo V; De Salvo L; Simone G; Papalia R; Picardo F; Balsamo T; Flammia GP; Trombetta D; Pantalone A; Kok K; Paranita F; Muscarella LA; Fazio VM
Oncotarget; 2017 Feb; 8(7):11187-11198. PubMed ID: 28061437
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
28. Crosstalk between TLR5 and Notch1 signaling in epithelial cells during intestinal inflammation.
Aziz M; Ishihara S; Ansary MU; Sonoyama H; Tada Y; Oka A; Kusunoki R; Tamagawa Y; Fukuba N; Mishima Y; Mishiro T; Oshima N; Moriyama I; Ishimura N; Sato S; Yuki T; Kawashima K; Kinoshita Y
Int J Mol Med; 2013 Nov; 32(5):1051-62. PubMed ID: 24048326
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of Notch pathway molecules in oral squamous cell carcinoma.
Hijioka H; Setoguchi T; Miyawaki A; Gao H; Ishida T; Komiya S; Nakamura N
Int J Oncol; 2010 Apr; 36(4):817-22. PubMed ID: 20198324
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer.
Piazzi G; Fini L; Selgrad M; Garcia M; Daoud Y; Wex T; Malfertheiner P; Gasbarrini A; Romano M; Meyer RL; Genta RM; Fox JG; Boland CR; Bazzoli F; Ricciardiello L
Oncotarget; 2011 Dec; 2(12):1291-301. PubMed ID: 22249198
[TBL] [Abstract][Full Text] [Related]
32. Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis.
Mancarella S; Serino G; Dituri F; Cigliano A; Ribback S; Wang J; Chen X; Calvisi DF; Giannelli G
Cell Death Differ; 2020 Aug; 27(8):2330-2343. PubMed ID: 32042099
[TBL] [Abstract][Full Text] [Related]
33. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.
Wang K; Zhang Q; Li D; Ching K; Zhang C; Zheng X; Ozeck M; Shi S; Li X; Wang H; Rejto P; Christensen J; Olson P
Clin Cancer Res; 2015 Mar; 21(6):1487-96. PubMed ID: 25564152
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma.
Evelönn EA; Landfors M; Haider Z; Köhn L; Ljungberg B; Roos G; Degerman S
BMC Cancer; 2019 Jan; 19(1):65. PubMed ID: 30642274
[TBL] [Abstract][Full Text] [Related]
35. No evidence for a functional role of bi-directional Notch signaling during angiogenesis.
Liebler SS; Feldner A; Adam MG; Korff T; Augustin HG; Fischer A
PLoS One; 2012; 7(12):e53074. PubMed ID: 23300864
[TBL] [Abstract][Full Text] [Related]
36. Genetic alteration in notch pathway is associated with better prognosis in renal cell carcinoma.
Feng C; Xiong Z; Jiang H; Ding Q; Fang Z; Hui W
Biofactors; 2016; 42(1):41-8. PubMed ID: 26662507
[TBL] [Abstract][Full Text] [Related]
37. γ-secretase inhibitor DAPT mitigates cisplatin-induced acute kidney injury by suppressing Notch1 signaling.
Soni H; Matthews AT; Pallikkuth S; Gangaraju R; Adebiyi A
J Cell Mol Med; 2019 Jan; 23(1):260-270. PubMed ID: 30407728
[TBL] [Abstract][Full Text] [Related]
38. Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.
El Khatib M; Bozko P; Palagani V; Malek NP; Wilkens L; Plentz RR
PLoS One; 2013; 8(10):e77433. PubMed ID: 24204826
[TBL] [Abstract][Full Text] [Related]
39. Notch-1 signaling regulates microglia activation via NF-κB pathway after hypoxic exposure in vivo and in vitro.
Yao L; Kan EM; Kaur C; Dheen ST; Hao A; Lu J; Ling EA
PLoS One; 2013; 8(11):e78439. PubMed ID: 24223152
[TBL] [Abstract][Full Text] [Related]
40. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
